Publications by authors named "Weifan Jiang"

Claim this Profile
N
N(14)-phenyl-substituted evodiamine derivatives for the treatment of superficial fungal infections by inhibiting xanthine dehydrogenase.
Ying Peng, Yan Peng, Jiachen Li, Yu Zhang, Xi Zhang, Weifan Jiang

Bioorg Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Carbamate-Based o-aminobenzamide Derivatives as Potent Antigastric Carcinoma Agents via Disrupting NAD Salvage Synthesis.
Siyi Zhang, Zhen Li, Bo Li, Zhiyi Li, Huiqian Peng, Weifan Jiang

J Med Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Video platforms and sexual healthcare in China: assessment of content on premature ejaculation.
Hao-Yang Lu, Rong-Hao Zhang, Xi Wen, Yi Wang, Ke-Qiu Wu, Wei-Fan Jiang

Transl Androl Urol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship study of novel evodiamine amino acid conjugates with potent anti-colorectal cancer efficacy.
Shuting Chen, Xi Zhang, Hanxuan Mo, Ying Peng, Zhigang An, Weifan Jiang

Eur J Med Chem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fenamates: Forgotten treasure for cancer treatment and prevention: Mechanisms of action, structural modification, and bright future.
Junfang Li, Xiaodong Wang, Honghua Zhang, Xiaoling Hu, Xue Peng, Weifan Jiang

Med Res Rev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel 10-hydroxyevodiamine prodrug as a potent topoisomerase inhibitor with improved aqueous solubility for treatment of hepatocellular carcinoma.
Xiuzhen Wei, Xi Zhang, Yan Peng, Junbo Wu, Hanxuan Mo, Weifan Jiang

Eur J Med Chem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel -phenyl-2-(aniline) benzamide hydrochloride salt development for colon cancer therapy.
Yan Peng, Ying Peng, Wei Zhang, Siyi Zhang, Huiqian Peng, Weifan Jiang

Front Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel small molecules targeting the USP21/JAK2/STAT3 axis for the treatment of triple-negative breast cancer.
Lin Long, Jiachi Xu, Xiaowen Qi, Yan Pen, Chengkun Wang, Weifan Jiang

Eur J Med Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship study of 1,6-naphthyridinone derivatives as selective type II AXL inhibitors with potent antitumor efficacy.
Linsheng Zhuo, Mengqin Guo, Siyi Zhang, Junbo Wu, Mingshu Wang, Weifan Jiang

Eur J Med Chem· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Therapeutic Effects of Multifunctional -Salicylic Acid Tryptamine Derivative against Parkinson's Disease.
Xuelin Li, Shuzhi Wang, Shan Duan, Lin Long, Linsheng Zhuo, Weifan Jiang

ACS Omega· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N(14)-substituted evodiamine derivatives as dual topoisomerase 1/tubulin-Inhibiting anti-gastrointestinal tumor agents.
Jiedan Deng, Lin Long, Xue Peng, Weifan Jiang, Ying Peng

Eur J Med Chem· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of -aminobenzamide salt derivatives for improving water solubility and anti-undifferentiated gastric cancer.
Shuang Li, Yanli He, Xuelin Li, Yongxia Xiong, Yan Peng, Weifan Jiang

Front Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction for: Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma.
Fang Jiayu, Yike Jiang, Xuanrui Zhou, Minqin Zhou, Jingying Pan, Weifan Jiang

Aging (Albany NY)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural product evodiamine-inspired medicinal chemistry: Anticancer activity, structural optimization and structure-activity relationship.
Zhen Wang, Yongxia Xiong, Ying Peng, Xi Zhang, Shuang Li, Weifan Jiang

Eur J Med Chem· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma.
Fang Jiayu, Yike Jiang, Xuanrui Zhou, Minqin Zhou, Jingying Pan, Weifan Jiang

Aging (Albany NY)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of dual inhibitors of topoisomerase I and Cyclooxygenase-2 for colon cancer therapy.
Xiaoling Hu, Junfang Li, Honghua Zhang, Quanwei Yu, Yuying Wang, Weifan Jiang

Eur J Med Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of carbamate-based N-salicyloyl tryptamine derivatives as novel pleiotropic agents for the treatment of Alzheimer's disease.
Yuying Wang, Honghua Zhang, Dan Liu, Xuelin Li, Lin Long, Weifan Jiang

Bioorg Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pure laparoscopic radical nephroureterectomy for complicated renal pelvis carcinoma combined with horseshoe kidney: A case report and literature review.
Ruizhen Huang, Jie Tian, Weifan Jiang

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of a histone deacetylase inhibitor plus exemestane with exemestane alone in hormone receptor-positive advanced breast cancer that progressed on prior endocrine therapy: A meta-analysis.
Liang Xu, Weifan Jiang, Wenwei Li, Chungen Guo, Lihua Luo

Exp Ther Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
-
-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression.
Junfang Li, Xiaoling Hu, Honghua Zhang, Yan Peng, Shuang Li, Weifan Jiang

J Med Chem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase I and II dual inhibitors for the therapy of liver cancer.
Xuemei Deng, Tian Luo, Xi Zhang, Yuehua Li, Liming Xie, Weifan Jiang

Eur J Med Chem· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E3 ubiquitin ligase RBX1 drives the metastasis of triple negative breast cancer through a FBXO45-TWIST1-dependent degradation mechanism.
Jun Shao, Qian Feng, Weifan Jiang, Yuting Yang, Zhiqiang Liu

Aging (Albany NY)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and biological evaluation of novel o-aminobenzamide derivatives as potential anti-gastric cancer agents in vitro and in vivo.
Yiyue Feng, Yingmei Lu, Junfang Li, Honghua Zhang, Zhao Li, Weifan Jiang

Eur J Med Chem· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel piperazine based benzamide derivatives as potential anti-glioblastoma agents inhibiting cell proliferation and cell cycle progression.
Yingmei Lu, Yiyue Feng, Zhao Li, Junfang Li, Honghua Zhang, Weifan Jiang

Eur J Med Chem· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of two-period cross-over design on the bioequivalence study of gefitinib tablets in beagle dogs.
Tianming Dai, Weifan Jiang, Min Wang, Zizheng Guo, Renke Dai

Eur J Pharm Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis